[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Live Attenuated Vaccines Market Report 2017

August 2017 | 113 pages | ID: U012B3E633DEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Live Attenuated Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Live Attenuated Vaccines in these regions, from 2012 to 2022 (forecast).
United States Live Attenuated Vaccines market competition by top manufacturers/players, with Live Attenuated Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Merial
  • QYH Biotech
  • DHN
  • HVRI
  • CEVA
  • Elanco
  • Yebio
  • Zoetis
  • FATRO
  • Kyoto Biken
  • CAVAC
  • Ringpu Biology
  • Vaksindo
  • ChengDu Tecbond
  • Sindh Poultry Vaccine Centre
  • Merck Animal Health
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Companion Animals
  • Livestock Animals
  • Equine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Live Attenuated Vaccines for each application, including
  • Veterinary Clinics
  • Veterinary Hospitals
  • Others
United States Live Attenuated Vaccines Market Report 2017

1 LIVE ATTENUATED VACCINES OVERVIEW

1.1 Product Overview and Scope of Live Attenuated Vaccines
1.2 Classification of Live Attenuated Vaccines by Product Category
  1.2.1 United States Live Attenuated Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Live Attenuated Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Companion Animals
  1.2.4 Livestock Animals
  1.2.5 Equine
1.3 United States Live Attenuated Vaccines Market by Application/End Users
  1.3.1 United States Live Attenuated Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Veterinary Clinics
  1.3.3 Veterinary Hospitals
  1.3.4 Others
1.4 United States Live Attenuated Vaccines Market by Region
  1.4.1 United States Live Attenuated Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Live Attenuated Vaccines Status and Prospect (2012-2022)
  1.4.3 Southwest Live Attenuated Vaccines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Live Attenuated Vaccines Status and Prospect (2012-2022)
  1.4.5 New England Live Attenuated Vaccines Status and Prospect (2012-2022)
  1.4.6 The South Live Attenuated Vaccines Status and Prospect (2012-2022)
  1.4.7 The Midwest Live Attenuated Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Live Attenuated Vaccines (2012-2022)
  1.5.1 United States Live Attenuated Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 United States Live Attenuated Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES LIVE ATTENUATED VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Live Attenuated Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Live Attenuated Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Live Attenuated Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Live Attenuated Vaccines Market Competitive Situation and Trends
  2.4.1 United States Live Attenuated Vaccines Market Concentration Rate
  2.4.2 United States Live Attenuated Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Live Attenuated Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LIVE ATTENUATED VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Live Attenuated Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Live Attenuated Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Live Attenuated Vaccines Price by Region (2012-2017)

4 UNITED STATES LIVE ATTENUATED VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Live Attenuated Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Live Attenuated Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Live Attenuated Vaccines Price by Type (2012-2017)
4.4 United States Live Attenuated Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES LIVE ATTENUATED VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Live Attenuated Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Live Attenuated Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES LIVE ATTENUATED VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merial
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Live Attenuated Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merial Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 QYH Biotech
  6.2.2 Live Attenuated Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 QYH Biotech Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 DHN
  6.3.2 Live Attenuated Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 DHN Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 HVRI
  6.4.2 Live Attenuated Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 HVRI Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 CEVA
  6.5.2 Live Attenuated Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 CEVA Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Elanco
  6.6.2 Live Attenuated Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Elanco Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Yebio
  6.7.2 Live Attenuated Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Yebio Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Zoetis
  6.8.2 Live Attenuated Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Zoetis Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 FATRO
  6.9.2 Live Attenuated Vaccines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 FATRO Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Kyoto Biken
  6.10.2 Live Attenuated Vaccines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Kyoto Biken Live Attenuated Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 CAVAC
6.12 Ringpu Biology
6.13 Vaksindo
6.14 ChengDu Tecbond
6.15 Sindh Poultry Vaccine Centre
6.16 Merck Animal Health

7 LIVE ATTENUATED VACCINES MANUFACTURING COST ANALYSIS

7.1 Live Attenuated Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Live Attenuated Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Live Attenuated Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Live Attenuated Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LIVE ATTENUATED VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Live Attenuated Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Live Attenuated Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Live Attenuated Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Live Attenuated Vaccines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Live Attenuated Vaccines
Figure United States Live Attenuated Vaccines Market Size (M Units) by Type (2012-2022)
Figure United States Live Attenuated Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Companion Animals Product Picture
Figure Livestock Animals Product Picture
Figure Equine Product Picture
Figure United States Live Attenuated Vaccines Market Size (M Units) by Application (2012-2022)
Figure United States Sales Market Share of Live Attenuated Vaccines by Application in 2016
Figure Veterinary Clinics Examples
Figure Veterinary Hospitals Examples
Figure Others Examples
Figure United States Live Attenuated Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Live Attenuated Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Live Attenuated Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Live Attenuated Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Live Attenuated Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Live Attenuated Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Live Attenuated Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Live Attenuated Vaccines Sales (M Units) and Growth Rate (2012-2022)
Figure United States Live Attenuated Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Live Attenuated Vaccines Market Major Players Product Sales Volume (M Units) (2012-2017)
Table United States Live Attenuated Vaccines Sales (M Units) of Key Players/Suppliers (2012-2017)
Table United States Live Attenuated Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Live Attenuated Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Live Attenuated Vaccines Sales Share by Players/Suppliers
Figure United States Live Attenuated Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Live Attenuated Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Live Attenuated Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Live Attenuated Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Live Attenuated Vaccines Revenue Share by Players/Suppliers
Table United States Market Live Attenuated Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Live Attenuated Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Live Attenuated Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Live Attenuated Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Live Attenuated Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Live Attenuated Vaccines Product Category
Table United States Live Attenuated Vaccines Sales (M Units) by Region (2012-2017)
Table United States Live Attenuated Vaccines Sales Share by Region (2012-2017)
Figure United States Live Attenuated Vaccines Sales Share by Region (2012-2017)
Figure United States Live Attenuated Vaccines Sales Market Share by Region in 2016
Table United States Live Attenuated Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Live Attenuated Vaccines Revenue Share by Region (2012-2017)
Figure United States Live Attenuated Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Live Attenuated Vaccines Revenue Market Share by Region in 2016
Table United States Live Attenuated Vaccines Price (USD/Unit) by Region (2012-2017)
Table United States Live Attenuated Vaccines Sales (M Units) by Type (2012-2017)
Table United States Live Attenuated Vaccines Sales Share by Type (2012-2017)
Figure United States Live Attenuated Vaccines Sales Share by Type (2012-2017)
Figure United States Live Attenuated Vaccines Sales Market Share by Type in 2016
Table United States Live Attenuated Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Live Attenuated Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Live Attenuated Vaccines by Type (2012-2017)
Figure Revenue Market Share of Live Attenuated Vaccines by Type in 2016
Table United States Live Attenuated Vaccines Price (USD/Unit) by Types (2012-2017)
Figure United States Live Attenuated Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Live Attenuated Vaccines Sales (M Units) by Application (2012-2017)
Table United States Live Attenuated Vaccines Sales Market Share by Application (2012-2017)
Figure United States Live Attenuated Vaccines Sales Market Share by Application (2012-2017)
Figure United States Live Attenuated Vaccines Sales Market Share by Application in 2016
Table United States Live Attenuated Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Live Attenuated Vaccines Sales Growth Rate by Application (2012-2017)
Table Merial Basic Information List
Table Merial Live Attenuated Vaccines Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merial Live Attenuated Vaccines Sales Growth Rate (2012-2017)
Figure Merial Live Attenuated Vaccines Sales Market Share in United States (2012-2017)
Figure Merial Live Attenuated Vaccines Revenue Market Share in United States (2012-2017)
Table QYH Biotech Basic Information List
Table QYH Biotech Live Attenuated Vaccines Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure QYH Biotech Live Attenuated Vaccines Sales Growth Rate (2012-2017)
Figure QYH Biotech Live Attenuated Vaccines Sales Market Share in United States (2012-2017)
Figure QYH Biotech Live Attenuated Vaccines Revenue Market Share in United States (2012-2017)
Table DHN Basic Information List
Table DHN Live Attenuated Vaccines Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure DHN Live Attenuated Vaccines Sales Growth Rate (2012-2017)
Figure DHN Live Attenuated Vaccines Sales Market Share in United States (2012-2017)
Figure DHN Live Attenuated Vaccines Revenue Market Share in United States (2012-2017)
Table HVRI Basic Information List
Table HVRI Live Attenuated Vaccines Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure HVRI Live Attenuated Vaccines Sales Growth Rate (2012-2017)
Figure HVRI Live Attenuated Vaccines Sales Market Share in United States (2012-2017)
Figure HVRI Live Attenuated Vaccines Revenue Market Share in United States (2012-2017)
Table CEVA Basic Information List
Table CEVA Live Attenuated Vaccines Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CEVA Live Attenuated Vaccines Sales Growth Rate (2012-2017)
Figure CEVA Live Attenuated Vaccines Sales Market Share in United States (2012-2017)
Figure CEVA Live Attenuated Vaccines Revenue Market Share in United States (2012-2017)
Table Elanco Basic Information List
Table Elanco Live Attenuated Vaccines Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Elanco Live Attenuated Vaccines Sales Growth Rate (2012-2017)
Figure Elanco Live Attenuated Vaccines Sales Market Share in United States (2012-2017)
Figure Elanco Live Attenuated Vaccines Revenue Market Share in United States (2012-2017)
Table Yebio Basic Information List
Table Yebio Live Attenuated Vaccines Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Yebio Live Attenuated Vaccines Sales Growth Rate (2012-2017)
Figure Yebio Live Attenuated Vaccines Sales Market Share in United States (2012-2017)
Figure Yebio Live Attenuated Vaccines Revenue Market Share in United States (2012-2017)
Table Zoetis Basic Information List
Table Zoetis Live Attenuated Vaccines Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Zoetis Live Attenuated Vaccines Sales Growth Rate (2012-2017)
Figure Zoetis Live Attenuated Vaccines Sales Market Share in United States (2012-2017)
Figure Zoetis Live Attenuated Vaccines Revenue Market Share in United States (2012-2017)
Table FATRO Basic Information List
Table FATRO Live Attenuated Vaccines Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure FATRO Live Attenuated Vaccines Sales Growth Rate (2012-2017)
Figure FATRO Live Attenuated Vaccines Sales Market Share in United States (2012-2017)
Figure FATRO Live Attenuated Vaccines Revenue Market Share in United States (2012-2017)
Table Kyoto Biken Basic Information List
Table Kyoto Biken Live Attenuated Vaccines Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kyoto Biken Live Attenuated Vaccines Sales Growth Rate (2012-2017)
Figure Kyoto Biken Live Attenuated Vaccines Sales Market Share in United States (2012-2017)
Figure Kyoto Biken Live Attenuated Vaccines Revenue Market Share in United States (2012-2017)
Table CAVAC Basic Information List
Table Ringpu Biology Basic Information List
Table Vaksindo Basic Information List
Table ChengDu Tecbond Basic Information List
Table Sindh Poultry Vaccine Centre Basic Information List
Table Merck Animal Health Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Live Attenuated Vaccines
Figure Manufacturing Process Analysis of Live Attenuated Vaccines
Figure Live Attenuated Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Live Attenuated Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Live Attenuated Vaccines
Table Distributors/Traders List
Figure United States Live Attenuated Vaccines Sales Volume (M Units) and Growth Rate Forecast (2017-2022)
Figure United States Live Attenuated Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Live Attenuated Vaccines Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Live Attenuated Vaccines Sales Volume (M Units) Forecast by Type (2017-2022)
Figure United States Live Attenuated Vaccines Sales Volume (M Units) Forecast by Type (2017-2022)
Figure United States Live Attenuated Vaccines Sales Volume (M Units) Forecast by Type in 2022
Table United States Live Attenuated Vaccines Sales Volume (M Units) Forecast by Application (2017-2022)
Figure United States Live Attenuated Vaccines Sales Volume (M Units) Forecast by Application (2017-2022)
Figure United States Live Attenuated Vaccines Sales Volume (M Units) Forecast by Application in 2022
Table United States Live Attenuated Vaccines Sales Volume (M Units) Forecast by Region (2017-2022)
Table United States Live Attenuated Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Live Attenuated Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Live Attenuated Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories